BRIAN RAMOS: Open Payments
NPI 1205553815 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$577 in 21 payments from 12 companies in 2025. Trend: 2023 $60 · 2024 $647 · 2025 $577
Food & beverage: $577
| Company | Payments | Amount |
|---|---|---|
| Kerecis Limited | 2 | $191 |
| ABBVIE INC. | 4 | $72 |
| Paratek Pharmaceuticals, Inc. | 3 | $63 |
| Solventum Corporation | 2 | $58 |
| MIMEDX Group, Inc. | 1 | $35 |
| Melinta Therapeutics, LLC | 2 | $30 |
| HARTMANN USA, INC. | 2 | $30 |
| Organogenesis Inc. | 1 | $24 |
| COLOPLAST CORP | 1 | $21 |
| Urgo Medical North America, LLC | 1 | $20 |
Products named: Kerecis SurgiClose, NUZYRA, ACTIV.A.C., TEFLARO, Kimyrsa, APLIGRAF, DALVANCE, InterDry.
Industry payments across TX — which companies pay providers there.
